Guardant Health GH
$145.83 +$0.24 (+0.16%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $145.83 0.00%
Open$143.10
Prev close$145.59
Day range$141.01 – $148.27
Volume2.76M
Market cap$19.73B
P/E (TTM)–
Dividend yield–
GH Stock News
Headlines matching Guardant Health or the GH ticker, most recent first.
- Bernstein Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $210 Positive
- Goldman Sachs Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $210
- William Blair Maintains Guardant Health(GH.US) With Buy Rating
- Rothschild & Co Redburn Initiates Guardant Health(GH.US) With Buy Rating, Announces Target Price $203
- Bernstein Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $210
- Goldman Sachs Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $225 Positive
- BTIG Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $195
- Analysts Are Bullish on These Healthcare Stocks: Fractyl Health, Inc. (GUTS), Guardant Health (GH) Positive
- Barclays Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $200
- Analysts Are Bullish on These Healthcare Stocks: NeurAxis, Inc. (NRXS), Guardant Health (GH) Positive
- Craig-Hallum Maintains Guardant Health(GH.US) With Buy Rating
- Piper Sandler Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $193
- A Quick Look at Today's Ratings for Guardant Health(GH.US), With a Forecast Between $180 to $220
- Barclays Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $220
- Bernstein Maintains Guardant Health(GH.US) With Buy Rating, Cuts Target Price to $190 Negative
No comments yet — be the first to weigh in on GH.
Sign in to join the discussion.